Recent Advances in the Treatment of Interstitial Lung Disease in Patients with Polymyositis/Dermatomyositis

E-ISSN： 2212-3873|6|4|409-415

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.4, 2006-12, pp. : 409-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologics in Polymyositis and Dermatomyositis-Associated Interstitial Lung Disease

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 521-524

Bentham Science Publishers

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis: Pathophysiology, Current and New Advances in Therapy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 266-277

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease

By Kelly Clive Saravanan Vadivelu

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3221-3230

Informa Healthcare

Access to resources Recommend Favorite

Amrubicin: First report of interstitial lung disease: 7 patients

Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Oxaliplatin: Interstitial lung disease in elderly patients: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1368, 2011-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite